Antihypertensive Drug News and Research RSS Feed - Antihypertensive Drug News and Research

Team-based care shown to be most effective way to control hypertension

Team-based care shown to be most effective way to control hypertension

Patients diagnosed with high blood pressure are given better control of their condition from a physician-pharmacist collaborative intervention than physician management alone, according to new research. [More]
Hypertensive patients who have psoriasis may need stricter blood pressure control

Hypertensive patients who have psoriasis may need stricter blood pressure control

People with hypertension who also have psoriasis may benefit from tighter blood pressure control, say researchers, particularly if their psoriasis is moderate or severe. [More]
Healthy lifestyle helps hard-to-treat hypertensive patients

Healthy lifestyle helps hard-to-treat hypertensive patients

Maintaining a healthy lifestyle can prevent cardiovascular events even among patients with apparent treatment-resistant hypertension, say researchers. [More]
Systolic, diastolic blood pressures may have different effects on different types of cardiovascular diseases

Systolic, diastolic blood pressures may have different effects on different types of cardiovascular diseases

Raised systolic and diastolic blood pressures may have different effects on different types of cardiovascular diseases and at different ages, according to new research involving 1.25 million patients from primary care practices in England published in a special themed issue of The Lancet. [More]
Simple approach best for blood pressure risk stratification

Simple approach best for blood pressure risk stratification

Calculating blood pressure load does not increase physicians’ ability to predict a patient’s risk of cardiovascular events, research shows. [More]
Treatable factors linked to blood pressure variability in diabetes

Treatable factors linked to blood pressure variability in diabetes

Some factors that are associated with variability in home blood pressure in patients with Type 2 diabetes may be open to intervention, research suggests. [More]
Physicians beware of fruity drug interactions

Physicians beware of fruity drug interactions

An understanding of the potential for pharmacokinetic interaction between orally administered drugs and grapefruit is necessary in view of an increase in marketed medications that fit the risk criteria, suggest Canadian researchers. [More]
Comprehensive overview of vascular risk factors to Alzheimer's disease

Comprehensive overview of vascular risk factors to Alzheimer's disease

Over the last 15 years, researchers have found a significant association between vascular diseases such as hypertension, atherosclerosis, diabetes type 2, hyperlipidemia, and heart disease and an increased risk of Alzheimer's disease. [More]
Men with cardiovascular risk factors more likely to develop peripheral artery disease

Men with cardiovascular risk factors more likely to develop peripheral artery disease

Among nearly 45,000 men who were followed up for more than two decades, those with the risk factors of smoking, hypertension, high cholesterol, and type 2 diabetes had an associated greater risk of developing PAD, according to a study in the October 24/31 issue of JAMA. [More]
Study examines link between alcohol consumption and AF in patients with cardiovascular disease

Study examines link between alcohol consumption and AF in patients with cardiovascular disease

An analysis of the association of alcohol consumption with the development of atrial fibrillation (AF) among subjects with coronary heart disease, stroke, diabetes, or other manifestations of cardiovascular disease (CVD) was based on subjects in two large antihypertensive drug treatment trials. [More]
Oil blend plus antihypertensive lowers blood pressure, cholesterol level

Oil blend plus antihypertensive lowers blood pressure, cholesterol level

A blend of sesame and rice bran oil could reduce blood pressure by almost as much as an antihypertensive medication, say researchers. [More]
Healthy behaviours decrease risk of high blood pressure by two thirds

Healthy behaviours decrease risk of high blood pressure by two thirds

Healthy behaviours regarding alcohol, physical activity, vegetable intake and body weight reduce the risk of hypertension by two thirds, according to research presented at the ESC Congress today. [More]
Power Over Pressure steering committee launches world's first hypertension online resource

Power Over Pressure steering committee launches world's first hypertension online resource

The Power Over Pressure steering committee today announced the launch of the world's first online resource created to help healthcare professionals improve diagnosis and develop solutions for treatment-resistant hypertension, an urgent and growing public health issue that affects 120 million people worldwide. [More]
Healthy lifestyle provides stroke prevention across hypertensive states

Healthy lifestyle provides stroke prevention across hypertensive states

Maintaining a healthy lifestyle significantly decreases the risk for stroke in both men and women who differ in their hypertension status and use of antihypertensive drug treatments, a study shows. [More]
Exercise hope for drug-resistant hypertension

Exercise hope for drug-resistant hypertension

Even patients who have hypertension despite taking multiple antihypertensive drugs can achieve blood pressure reductions with a program of aerobic exercise, research shows. [More]
Exercise hope for drug-resistant hypertension

Exercise hope for drug-resistant hypertension

Even patients who have hypertension despite taking multiple antihypertensive drugs can achieve blood pressure reductions with a program of aerobic exercise, research shows. [More]
Heart disease risk in elderly could be lowered by drugs

Heart disease risk in elderly could be lowered by drugs

More patients aged 75 and over should be prescribed drugs to help lower their risk of cardiovascular disease, a study published today on bmj.com suggests. [More]
MacuCLEAR to initiate MC-1101 Phase III studies on early-stage AMD

MacuCLEAR to initiate MC-1101 Phase III studies on early-stage AMD

MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA. [More]

Chlorthalidone may reduce risk of death in patients with systolic hypertension

Patients with systolic hypertension who were treated with the diuretic chlorthalidone for 4.5 years as part of a clinical trial had a significantly lower rate of death and a gain in life expectancy free from cardiovascular death about 20 years later compared to patients who received placebo, according to a study in the December 21 issue of JAMA. [More]
Antihypertensive drug therapy associated with longer life expectancy

Antihypertensive drug therapy associated with longer life expectancy

More than 68 percent of Americans 65 and older - 80 percent age 75 and over - have hypertension (high blood pressure), according to a 2010 report by the Centers for Disease Control. Left untreated, this chronic condition can lead to stroke, heart attack, heart failure or premature death. Researchers at UMDNJ-Robert Wood Johnson Medical School have shown in a follow-up to the landmark clinical trial, Systolic Hypertension in the Elderly Program (SHEP), that the use of antihypertensive drug therapy is associated with longer life expectancy. [More]